Literature DB >> 26198796

Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation.

I Schauer1, E Keller2, A Müller2, S Madersbacher1.   

Abstract

Based on case series, potency rates after radical prostatectomy (RPE) differ substantially and - furthermore - it remains unclear whether they have improved in more recent surgical series. The purpose of this study was to investigate whether potency rates after RPE have improved over the years. A systematic analysis of the control arms of all randomized controlled trials (RCT; n = 11) on penile rehabilitation after RPE was carried out. In total, 2009 patients were included in these RCTs, 685 thereof in the respective control arms, who were either observed or received placebo. Assessment of erectile function in these studies was carried out by the Sexual Encounter Profile (SEP) or the International Index of Erectile Function (IIEF). Eight trials used SEP3 as study endpoint. The rate of positive response to SEP3 (=erectile function sufficient for successful intercourse) in the control arms was 20% in 1997 (year of publication), 10% in 2003, 19% in 2004, 25% in 2008, 21% in 2010, 67% in 2011, 10% in 2013, and 22% in 2014. Eight RCTs assessed the IIEF-EF, yet results were not reported uniformly. In the control arms the IIEF-EF was 9.2 (year of publication 2003), 13.3 (2004), 8.8 (2008), 25% ≥22.0 (2008), 17.4 (2010), 58% ≥26.0 (2011), 9.3 (2013), and 11.6 (2014). Limitations of this analysis are a positive selection bias regarding patient recruitment, surgical approach, and the non-uniform inclusion and outcome criteria. This systematic analysis of the control arms of all RCTs on penile rehabilitation after nerve-sparing RPE shows (i) that the rate of undisturbed erectile function is in the range 20-25% in most studies and (ii) that these rates have not substantially improved or changed over the past 17 years.
© 2015 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  International Index of Erectile Function; SEP3; erectile dysfunction; penile rehabilitation; radical prostatectomy

Mesh:

Year:  2015        PMID: 26198796     DOI: 10.1111/andr.12060

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  10 in total

Review 1.  Contemporary treatments in prostate cancer focal therapy.

Authors:  Michael Ahdoot; Amir H Lebastchi; Baris Turkbey; Bradford Wood; Peter A Pinto
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

Review 2.  Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes.

Authors:  John R Heard; Aurash Naser-Tavakolian; Michael Nazmifar; Michael Ahdoot
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-03-04       Impact factor: 5.455

3.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

Review 4.  PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? | Opinion: Yes.

Authors:  Laith M Alzweri; Arthur L Burnett
Journal:  Int Braz J Urol       Date:  2017 May-Jun       Impact factor: 1.541

Review 5.  The controversy surrounding penile rehabilitation after radical prostatectomy.

Authors:  Jonathan Clavell-Hernández; Run Wang
Journal:  Transl Androl Urol       Date:  2017-02

6.  The Long-Term Effect of Radical Prostatectomy on Erectile Function, Urinary Continence, and Lower Urinary Tract Symptoms: A Comparison to Age-Matched Healthy Controls.

Authors:  Badereddin Mohamad Al-Ali; Anton Ponholzer; Herbert Augustin; Stephan Madersbacher; Karl Pummer
Journal:  Biomed Res Int       Date:  2017-02-05       Impact factor: 3.411

7.  Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy: A network meta-analysis.

Authors:  Jie Yang; Zhong-Yu Jian; Jia Wang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

8.  Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial.

Authors:  Martha Kirstine Haahr; Charlotte Harken Jensen; Navid Mohamadpour Toyserkani; Ditte Caroline Andersen; Per Damkier; Jens Ahm Sørensen; Lars Lund; Søren Paludan Sheikh
Journal:  EBioMedicine       Date:  2016-01-19       Impact factor: 8.143

9.  Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury.

Authors:  Chun-Hou Liao; Yi-No Wu; Bin-Huei Chen; Ying-Hung Lin; Hsiu-O Ho; Han-Sun Chiang
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

10.  Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats.

Authors:  Chun-Hou Liao; Kau-Han Lee; Shiu-Dong Chung; Kuo-Chiang Chen; Chellappan Praveen Rajneesh; Bo-He Chen; Jai-Hong Cheng; Wang-Ying Lin; Han-Sun Chiang; Yi-No Wu
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.